Local Spark Creates Momentum for International Success, SmartInvest Ventures Welcomes New Partner

WILMINGTON, Delaware, November 29, 2017 SmartInvest Ventures (“SmartInvest”), an international venture capital firm, announced today that Martin Hunt, joins the team as a general partner, along side Charles “Chuck” Kerrigan, Fred Hosaisy and managing general partner, Gerry Moan. With more than 25 years of experience in private equity, insurance, strategy consulting and investment banking with over $20 billion in M&A transactional experience, along with degrees from the Harvard Business School and Swarthmore College – where he was a McCabe scholar, Mr. Hunt brings both his expertise and local connections to SmartInvest’s newest geographical focus – Delaware.

Read More

ICON contributes to major European research study that aims to improve treatment for traumatic brain injury

Recommendations from the longitudinal observational research study will be presented today at the European Parliament  

Dublin, Ireland, 7 November 2017 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has contributed to a complex pan-European traumatic brain injury (TBI) research study involving over 4,500 patients in 65 sites in 20 European countries. ICON provided site management and source data verification (SDV) services to the study, which was supported by the European Union and led by Professor Andrew Maas from the University Hospital Antwerp (Belgium) and Professor David Menon from the University of Cambridge (UK).  ICON’s Dr. Valérie Legrand, VP Project Management and a recognised expert in CNS, also provided clinical expertise as a member of the project’s Management Committee. The Lancet Neurology Commission on TBI is being launched at the European Parliament today and will set out clinical and research priorities and recommendations to address the varied challenges in TBI.

Read More

Almac Group Announces Acquisition of BioClin Laboratories
Significant global expansion of existing analytical services

 

Craigavon, N.I., 01 November 2017Almac Group, the global contract development and manufacturing organisation, today announced the acquisition of 100% shares of BioClin Laboratories, an independent and privately owned organisation based in Athlone, Ireland.

Established in 2002 and located in Garrycastle, just two hours away from Almac Group’s Headquarters in Northern Ireland, BioClin is internationally recognised for providing expert analytical services including cGMP pharmaceutical and biopharmaceutical analysis, GMP microbiology testing and GLP bioanalysis. The company also boasts Ireland’s leading GLP certified (INAB), cGMP certified (HPRA) and FDA registered contract laboratory.

Read More

ICON and the International Consortium for Health Outcomes Measurement unveil the world’s first global patient outcomes benchmarking platform

Dublin, Ireland, 27 October 2017 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and the International Consortium for Health Outcomes Measurement (ICHOM), a non-profit organization with the mission of driving value based health care, shared the findings of a global patient outcomes benchmarking platform at this week’s ICHOM’s annual conference in Washington DC. The platform aims to catalyse physician driven learning and improvement of the outcomes that matter most to patients.

ICON and ICHOM first partnered to advance value-based healthcare through the launch of a global healthcare outcomes benchmarking pilot program called GLOBE in March 2016.

Read More

#IABCN members, Joe Burke (center) and Michael O’Rourke (far right) representing PA Trade Mission, meeting with Mayo County Council Economic Development Group this week.

PA Trade Mission visit to the McHale headquarters, just outside Ballinrobe, County Mayo.

#IABCN member, Joe Burke (2nd to left) with 2 Mayo County Council Economic Development Reps and (3rd from left) Paul McHale, Sales Manager; (center) Gene Barr, President & CEO of PA Chamber of Business and Industry; (2nd from right) Padraic McHale, Co-Owner and Founder.

McHale employs 250+, with 25% of their workforce is dedicated to R&D.